Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control

Despite U.S. Food and Drug Administration (FDA) approval of over 40 new treatment options for type 2 diabetes since 2005, the latest data from the National Health and Nutrition Examination Survey show that the proportion of patients achieving glycated hemoglobin (HbA )

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes care 2017-11, Vol.40 (11), p.1425-1432
Hauptverfasser:	Edelman, Steven V, Polonsky, William H
Format:	Artikel
Sprache:	eng
Schlagworte:	Adhesion Blood Glucose - metabolism Clinical outcomes Clinical trials Databases, Factual Diabetes Diabetes mellitus Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - epidemiology Drugs Glucose monitoring Glycated Hemoglobin A - analysis Government programs Health care Health Maintenance Organizations Hemoglobin Humans Hypoglycemic Agents - therapeutic use Medicaid Medical research Medication Adherence Nutrition Nutrition Surveys Patients Randomized Controlled Trials as Topic Regulatory agencies United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Despite U.S. Food and Drug Administration (FDA) approval of over 40 new treatment options for type 2 diabetes since 2005, the latest data from the National Health and Nutrition Examination Survey show that the proportion of patients achieving glycated hemoglobin (HbA )
ISSN:	0149-5992 1935-5548
DOI:	10.2337/dc16-1974